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H EPATIC TRANSPLANTATION, even in experimental animals, is a product of recent times. The first attempts to transfer a whole liver from one dog 
to another were made by Welch 78 only 14 years ago. In his experiments, the 
liver was revascularized in the right paravertebral gutter of the recipient 
without disturbing the host organ (auxiliary transplantation). 
Liver replacement (orthotopic transplantation) was described by Cannon 10 
in 1956, although the procedure led to the immediate death of all of his 
animals. A short time later, programs to investigate orthotopic transplantation 
in dogs were independently begun at the Peter Bent Brigham Hospital under 
the direction of Francis D. Moore 42 . 43 and in our own laboratories at North-
western University.Go.sl Since then, a very complete picture has emerged about 
the technical requirements for these operations, the features of rejection which 
can be expected with or without immunosuppressive therapy, and the organ-
specific complications which make the transplantation of hepatic homografts 
an unusually difficult undertaking. 
Literature about experimental liver transplantation has grown exponentially 
in the last few years and has been reviewed exhaustively in a recent text. D4 In 
this chapter, the same material wiII not be recapitulated. Instead, an attempt 
will be made to develop a clinical point of view about liver transplantation 
based upon the stiU small, but highly Significant, human experience. In trying 
to meet this objective, laboratory research will be alluded to only as it directly 
relates to problems that have been encountered in man. 
CANDIDACY FOR OPERATION 
The potential usefulness of liver transplantation can be appreciated by the 
fact that more than 5,000 in 'Creat Britain 75 and 15,000 persons in the United 
States 13 die of liver disease each year, excluding infants with biliary atresia. 
Admittedly, only a fraction of such potential patients could be treated with 
liver transplantation, since it is highly desirable that recipients be relatively 
young (prefembly under 45 years), free of disease in other organs, and psy-
chologicaUy equipped to withstand the rigors of postoperative therapy. The 
last condition might \'lell preclude the majority of those with alcoholic cir-
rhosis. The potential pool is constantly further narrowed by the fact that a 
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person who is a legitimate candidate for liver transplantation usually cannot 
wait long for definitive treatment to be instituted. A host of complications, 
such as gastrointestinal ulceration, bleeding diathesis, renal failure and coma 
may cause death before the only operation can be attempted which might 
hold any hope of survival. 
Primary Hepatic Malignancy 
\iVith liver-cell or duct-cell carcinoma that cannot be excised with conven-
tional technics of subtotal liver resection, removal of the diseased organ is 
obligatory if the treatment is to be transplantation. It is important to carry 
out a systematic search for extrahepatic spread with chest x-rays, bone surveys 
and bone marrow examinations. In spite of these precautions, it is usually not 
possible to make a final decision for or against organ replacement until a 
cadaveric liver has become available and exploration carried out. In several 
cases, the effort has been abandoned at the last minute when tumor was 
found outside the liver. 
Liver Metastases 
At the present time, it seems doubtful that orthotopic hepatic transplan-
tation will be a useful way of treating metastases, even when these are appar-
ently confined to the liver. The reasons for this view or even for a pessimistic 
attitude about the value of such treatment for primary hepatic malignancies 
will be considered later. There have been only 2 examples of liver trans-
plantation for secondary hepatic neoplasms. The diagnosis was known in 
Demirleau's case,lG but in Moore's the preoperative impression of hepatoma 
had to be revised when a small primary carcinoma of the sigmoid colon was 
found at autopsy, 11 days after transplantation. 41 
Non-neoplastic Diseases 
The central issues are if and when to proceed, whether or not to use an 
auxiliary or orthotopic homograft, and what the life expectancy might be with-
out this heroic form of treatment. 
Congenital biliary atresia. The decision is not difficult jf the diagnosis is 
extrahepatic atresia, a disease in which survival is uncommon for more than 
two and essentially unheard of for more than four or five years. 26 Moreover, 
there are factors favoring the orthotopic in preference to the auxiliary opera-
tion beyond the fact that the latter procedure has special physiologic disad-
vantages as will be discussed later. The mechanical handicap to respiration 
imposed by the hepatomegaly and splenomegaly in these infants is eliminated 
by removal of both organs in the course of orthotopic homotransplantation. If 
an auxiliary transplant is attempted, there is little room in the already over-
crowded abdomen for another large organ as was well illustrated by Absolon's 
case. 1 
If the diagnosis is intrahepatic atresia, a distinction that can usually be made 
with biopsy, a doubly cautious attitude is necessary in recommending trans-
plantation. In a few children with intrahepatic atresia, survival for 10 years 
or longer has been recorded. 25,30, 71 
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Postnecrotic alld alcoholic cirrhosis. There have been few recorded attempts 
to treat cirrhosis with liver transplantation, probably for two reasons. Often, 
cadaveric organs cannot be obtained when they are needed. Consequently, a 
number of prospective recipients have died in our inst.itutions and elsewhere 
""hile awaiting hepatic homografts. Secondly, there has been a reluctance on 
the part of all concerned to consider this procedure at any other time than 
just before death, since the benefit that might come from intervention was 
entirely unproven and had to be balanced against the chance, however remote, 
that spontaneous improvement might occur. Now that the possibility of obtain-
ing extended survival has been established, it may become possible to relax 
the indications for operation, particularly in cases of postnccrotic cirrhosis, 
where the maximum value of abstinence from alcohol has already been 
realized. 
The question of which kind of operation to offer such patients has not been 
answered, but will probably be contingent upon the circumstances of organ 
supply. For example, if the liver of an infant or child became available for 
an adult, it might be best to place it as an auxiliary organ. On the other hand, 
an adult liver would be placed orthotopically, if it were thought that such a 
procedure could be tolerated. 
Other chronic diseases. Chronic hepatic failure due to less common diseases 
should also be amenable to treatment by liver transplantation. Examples could 
include primary biliary cirrhosis, Wilson's hepatolenticular degeneration, irrep-
arable biliary tract injury and hemochromatosis. To our knowledge, liver 
transplantation has not been attempted for any of these indications. 
Other intriguing possibilities stem from the recent disclosurcs that liver 
homografts retain their metabolic specificity after transfer to a new host. This 
was first shown by the studies of serum haptoglobins (Hp) and group speCific 
component (Gc) of the alpha2 globulin fraction in patients before and after 
orthotopic liver transplantation K OgI PTKr;~ In some of these cases, the donors had 
different Hp and Gc types than the recipients. After operation, the protein 
phenotypes completely and permanently became those previously present in 
the donors (Fig. 1). 
A practical implication of these demonstrations is that a number of liver-
based metabolic disorders 45,51 might bccomc treatable with eitlilCr orthotopic 
or auxiliary transplantation. The concept has been conclusively tested by 
Kuster et a1,29 Using mongrel canine donors, they were able to cure the gout 
naturally present in Dalmatian recipients. Conversely, the transplantation of 
Dalmatian livers conferred the defect in uric acid metabolism upon mongrel 
recipients. 
Acute liver failure. The role, if any, of transplantation in the treatment of 
fulminating viral or toxic hepatitis will probably be determined by clinical 
trial. Whether homografts placed in an auxiliary location might permit healing 
and regeneration of the gravely damaged host liver is open to some question. 
For one thing, the infecting virus in cases of hepatitis might contribute to the 
acute destruction of the homograft and, in addition, perhaps be made more 
virulent by the immunosuppression necessary to prevent homograft rejection. 
Even with acute yellow atrophy due to drugs or other toxic agents, it may be 
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FIG. I-Effect of orthotopic liver transplantation on serum haptoglobin (Hp). The 
patient had Smithies type 2-1; her donor was Hp type 2-2. After transplantation 
only the donor phenotype was detectable in the recipient sera. The determinations 
were by electrophoresis in a vertical starch geI.u 
found (see below) that metabolite competition by an auxiliary homograft 
could inhibit to a variable degree the recovery of the injured host liver. 
HOMOGRAFT PROCUREMENT AND STORAGE 
The only source of organs for hepatic transplantation is the recently de-
ceased cadaver. Because of the exceptional sensitivity of liver tissue to 
anoxia, the circumstances under which donation can be accepted are extremely 
limited. To begin with, it is almost mandatory that the imminence of death 
be known for at least several hours in advance. In addition, it is important that 
good circulation be maintained until just before the end of life, a condition 
which usually is found only in the victim of a massive and acute central nervous 
system injury. 
As soon as word is received that a potential cadaveric donor may be avail-
able, a number of examinations are carried out, including liver function tests. 
The ABO blood type is also an essential piece of information, since the donor 
either must be the same blood group as the recipient or have a blood type 
which permits the kind of pairing shown in Table 1.63 
In addition to red cell typing, study of lymphocyte antigens is immediately 
TABLE I-Direction of Acceptable Tissue Transfer when the Donor and Recipient 
have Different ABO Red Cell Types O 
o to non-O 
Rh- to Rh+ 
Rh+ to Rh-
A to non-A 
B to non-B 
AB to non-AB 
.. 0 is universal donor; AB is universal reCipient. 
Safe 
Safe 
Relatively Safe 
Dangerous 
Dangerous 
Dangerous 
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begun in order to establish the histocompatibility profile of the donor and to 
see how this matches with that present in any possible recipient. A full 
description of the techniques, virtues and deficiencies of histocompatibility 
analysis is beyond the scope of this presentation. However, there is growing 
evidence that such methods of prospective selection can be expected to reduce 
the difficulties with rejection that subsequently must be dealt with.15.72.76 
Other factors also are important in considering the advisability of using the 
liver from any given cadaveric donor. The role of age in determining the 
quality of the organ is important, but relatively unpredictable. Morgan and 
Feldman,11 Cohen et a1. 11 and Peters 48 have all provided evidence that per-
fectly adequate livers may often be present in the seventh or eighth decade of 
Hfe. However, it has been our recent policy not to take the chance that 
degenerative changes might be present and only livers from donors of less than 
4.5 years have been accepted. 
The Events of Death and Immediate Preservation 
The liver can be subjected to severe ischemia under normothermic condi-
tions with the expectation of prompt recovery, but only if the insult is of very 
short duration. Part or all of this slender margin of safety may be used up 
during the terminal hours or days of donor life if there is a protracted pre-
mortem interval of ineffective circulation. After death further tissue injury is 
inevitable; this can be minimized in various ways, including the institution of 
postmortem cardiac massage. 
However, the most important step is to cool the liver at once. This can be 
done simply (Fig. 2) by intraportal infusion of a chilled (2°C.) electrolyte solu-
tion. Alternatively, the entire cadaver or its lower half can be cooled by the 
use of postmortem cardiopulmonary bypass. "OKS~ With this technic, a heat 
exchanger is introduced into the circuit for temperature control (Fig. 3). The 
advantage of this approach is that the homograft is Simultaneously refrigerated 
and provided with an artificial circulation. 
Donor Hepatectomy 
The excision of the homograft is never begun until the homograft is cold; it 
can then be completed with 15 or 20 minutes if absolutely necessary. How-
ever, about an hour is required if the major hilar contents are to be carefully 
dissected, if all potential bleeding sites are to be ligated, and if long vascular 
cuffs are to be developed for later anastomosis. The use of cadaveric perfUSion, 
as described above, allows time for the more deliberate approach. 
The technical steps in removing the liver are straightforward and will not 
be described in detail. Several points, however, deserve special emphasis. It 
is important to try to develop as long a suprahepatic vena cava cuff as possible. 
During the hilar dissection, anomalies of the arterial blood supply must be 
looked for since they occur in about 25 per cent of cases. The most common 
deviation from normal is to have a right hepatic branch arise from the superior 
mesenteric artery and to have the left branch originate from the celiac axis 
(Fig.4C). 
In children it is often desirable to remove a segment of aorta in continuity 
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FIG. 2--Method of rapid core cooling of the human cadaveric liver by infusion of 
a chilled (2° C.) electrolyte solution via the splanchnic venous circulation. Immedi-
ately after entering the abdomen, a cannula is placed into the superior mesenteric 
vein, readily accessible at the base of the h'ansverse mesocolon. This vessel is far 
enough away from the portal triad so that the portal vein, which will ultimately be 
used for anastomosis, is not in danger of injury during the initial hasty dissection. 
Egress of the perfusate is provided for by a venotomy in the supra- or infrahepatic 
inferior vena cava. Bile is washed from the gallbladder through a cholecystotomy. 
(By permission of Ann. Surg. 168:392, 1968.) 
with the hepatic arterial supply (Fig. 5). One reason is that the option of 
performing an aorto-aortic anastomosis in the recipient is, thereby, left open. 
Another advantage is that the aorta can be used as a perfusion receptor if the 
extended preservation to be described below is to be carried out. 
Extended Preservation 
Until now there has been only one experimental technic for preserving 
excised canine livers which has permitted the use of the organs as orthotopic 
homo grafts after much longer than 2 hours. The method was reported in 
1967 1,5 and subsequently applied clinically. It employed a combination of 
hypothermia, hyperbaric oxygenation, and perfusion with diluted blood. The 
preservation chamber is shown schematically in Fig. 6. The details of flow, 
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FIG. 3-Technic of extracorporeal perfusion with cardiopulmonary bypass. 
Catheters are inserted via the femoral vessels into the aorta and inferior vena cava as 
soon as possible after death. The extracorporeal circuit is primed with a glucose or 
electrolyte solution to which procaine and heparin are added. The cadaver is, thus, 
anticoagulated with the first surge of the pump. Temperature control is provided by 
the heat exchanger. To limit perfusion to the lower part of the body, the thoracic 
aorta may be cross clamped as shown. (By permission of \\'. B. Saunders, 1964.) 
temperature control, compression and decompression, and acid base control 
were specified in previous publications.·I •G 
In dogs, it was found 4.G that canine livers could invariably support Me 
when placed as orthotopic homogmfts from 8-10 hours after donor sacrifice. 
Even after 24 hours recipient survival could often, though not always, be 
obtained. Similarly, life sustaining human livers have been preserved after 
death for as long as T~ hours.G,G' 
The Consequences of Hepatic Injury 
In almost all the first unsuccessful attempts at human liver transplanta-
tion 53,G8 , GO poor initial function of the homo grafts, which had been seriously 
damaged by anoxia, played an important or decisive role in the early fatal out-
come. The tissue injury was at least partly a re:8.ection of poor donor selection, 
inasmuch as the agonal period of donor life in these cases was almost always 
very protracted and characterized by a poor circulation. 
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FIG. 4--Variations in hepatic arterial reconstruction in recipients of orthotopiC 
homografts . 
(A) If no hepatic arterial anomalies are encountered in either the donor or recipient, 
the homograft common hepatic artery or celiac axis is usually anastomosed to the 
recipient proper or common hepatic artery. 
(B) The most common anatomic deviation is the presence of an anomalous right 
hepatic artery originating from the superior mesenteric artery. In one such case in 
which this anomaly was encountered in the donor, the left and right hepatic arteries 
of the homograft were individually anastomosed to the left and right branches of the 
recipient proper hepatic artery. 
(C) Alternatively, the homograft aorta may be anastomosed directly to the recipient 
aorta. Methods of reconstruction when similar anomalies are present in the recipient 
are shown in Fig. 13. Biliary drainage is established with cholecystoduodenostomy. 
(By permission of Ann. Surg.168:392, 1968.) 
In one of these early recipients a hemorrhagic diathesis ensued almost 
immediately, leading to death in 4 hours. There was massive fibrinolysis 69,77 
which was not affected by treatment with epsilon amino caproic acid (EACA), 
fresh blood and fibrinogen; at autopsy the liver was almost entirely necrotic. 
Several other recipients survived operation and a similar though less severe 
intraoperative bleeding diathesis, but died from 6-23 days after orthotopic 
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FIG. 5--Mobilization of the aorta during donor hepatectomy. Rapid identification 
and ligation of the branches is facilitated by applying variable b'action to the distal 
aorta. During the initial dissection, all the aortic branches except the celiac axis and 
superior mesenteric artery are ligated and divided ; the latter vessel is cut only after 
it has been shown not to give rise to an anomalous hepatic arterial branch. (By 
permission of Ann. Surg.168:392, 1968.) 
transplantation of multiple complications including hepatic insufficiency. In 
these patients, there were obvious defects in protein metabolism leading even-
tually to severely depressed levels of all protein fractions and clotting factors 
formed by the liver. Coincidentally, a large, third, fluid space was seen with 
ascites or even anasarca. Within a few days after operation jaundice became 
evident. 
At autopsy, the homografts in these unsuccessful early cases all had histo-
logic signs of previous severe ischemic damage. Invariably, there was necrosis, 
in some instances massive in extent. Most of the livers had little evidence of 
homograft rejection. Other serious complications such as gastrointestinal ul-
ceration and hemorrhage, pulmonary embolization or uncontrollable infection 
were the immediate cause of death. Nevertheless, acute hepatic insufficiency 
had played a prominent role in every instance. 
The livers used for all patients since the summer of 1967 have been of a 
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Vacuum 
inlet 
FIG. 6--Preservation unit. The perfusion pumps are located outside the hyperbaric 
chamber; the organ receptacle, the oxygenator and the venous reservoir are inside. 
The various chamber inlets permit sampling of the perfusate, gas sterilization, and 
oxygen delivery and removal. The temperature is electronically controlled. (By 
pe,mission of Surg. Gynec. Obstet. 126:263, 1968.) 
much higher quality, mainly because of more discriminating donor selection. 
In these last cases almost all the donors had short terminal illnesses and effec-
tive circulation until shortly before death. 54 ,56 ,57 In addition, many of the 
homografts were preserved in the efficient conservation apparatus alluded to 
above. The organs have provided adequate or excellent function in 11 of 14 
cases. The only exceptions were in 3 patients who developed acute occlusion 
of the common hepatic artery or portal vein. 
ORTHOTOPIC TRANSPLANTATION 
Recipient Technic 
In concept, the procedure is an extremely simple one involving only the 
reconstruction of vascular channels entering and leaving the liver, as well as 
provision for bile drainage. The ways in which these requirements have been 
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FIG. 7-Technic of reestablishing biliary drainage with choledochocholedochos-
tomy. A T tube is placed through a stab wound in the recipient portion of the recon-
structed common duct. Disruption of the anastomosis was the cause of death in 
one of the early cases. In all subsequent recipients, the common bile duct has been 
ligated and cholecystoduodenostomy performed (Figs. 4 and 13). 
met are shown in Figs. 4 and 13. A more physiologic means of reestablishing 
homograft biliary drainage than cholecystoduodenostomy would be with 
choledochocholedochostomy (Fig. 7). Disruption of the anastomosis caused 
the death of one of the recipients. Since then the common duct has been ligated 
and the gallbladder anastomosed to the duodenum in all cases (Fig. 4). 
There are factors which can render the operation difficult. Most patients 
who have a need for a liver homograft have more or less severe portal hyper-
tension which can make recipient hepatectomy a dangerous and bloody task 
and one which is further complicated by the huge size of some of the livers. 
Shown in Fig. 8 is the specimen removed from a 29-year-old woman. The 
liver and tumor weighed 20 pounds. 
A special technical pOint concerns the need, during the anhepatic phase, 
to occlude both the inferior vena cava and portal vein (Fig. 9). In dogs, the 
acute obstruction of the 2 venous beds for more than a few minutes is incom-
patible with life. To circumvent this difficulty, prosthetic bypasses have been 
used in laboratory research for temporary decompression (Fig. 10). The same 
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FIG. 8-The liver removed at the time of orthotopic homotransplantation from a 
29-year-old woman whose indication for transplantation was hepatoma. At operation 
a massive, multinodular tumor was found to have virtually replaced both hepatic 
lobes. There was no discernible tumor spread beyond the liver. 
kinds of devices were employed in the first clinical cases and may have con-
tributed to the pulmonary embolization which occurred in 3 of the first 4 
patients in our institutions who survived operation. s8, s9 ,77 
Subsequently, it has been learned that the human can tolerate cross clamp-
ing of both the portal vein and inferior vena cava for the time necessary to 
transplant the liver. 5G ,57 In patients with severe portal hypertension there have 
been almost no consequent cardiodynamic alterations and, even in recipients 
who had few venous collaterals, only minimal hypotension was seen. 
After completion of all the anastomoses, it is probably important to reattach 
the suspensory ligaments of the homograft to the companion structures in 
the recipient. When extended survival was finally obtained clinically, delayed 
thrombosis of the right hepatic artery developed in 5 of 6 consecutive infants 
and led to partial gangrene of the right lobe. Autopsy studies performed in an 
attempt to clarify the etiology suggested (Fig. 11) that the right lobe of livers 
that were not so reattached tended to rotate downward and medially and 
to partially kink the right hepatic artery. G7 
Immediate Mortality 
Early expeTience. From March 1963 to May 1967, 7 patients were treated 
with orthotopic homotransplantation. G3 ,68,69 In 5, the indication was primary 
hepatic malignancy and in the other 2 it was extrahepatic biliary atresia. One 
patient was 11 months old, a second was 3 years, and the other 5 were 29-
67 years. There was one immediate death and survival in the remainder of 
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FIG. 9-The operative field after human recipient hepatectomy. Note that both 
the inferior vena cava and portal vein are cross clamped during the anhepatic phase. 
The consequent acute obstruction of both venous beds is well tolerated in man with-
out bypass decompression, as is required in the dog. (By permission of Surg. Gynec. 
Obstet. 117:659,1963.) 
634, 7, 7!f, 10, 22, and 23 days. As mentioned earlier the use of badly or hope-
lessly damaged organs in these cases probably precluded long-term success. 
Moreover, it made evaluation of the effectiveness of immunosuppressive therapy 
an impossible task. These cases, which will not be considered further in this 
chapter, led to the decision '2.03 that further clinical trials would not be 
attempted until better technics of both immunosuppression and organ preser-
vation could be applied, and then not unless an effort could be made at pro-
spective histocompatibility typing. These objectives were met in the next 14 
cases. 
Later experiences. Fourteen more patients were treated with orthotopic 
liver transplantation from July 1967 until August 2, 1968. In this group there 
were 3 deaths in the immediate postoperative period. One patient, aged 11 
months, developed thrombosis of her homograft hepatic artery within a few 
hours after completion of the procedure. Almost immediately, she became 
somnolent and had a sharp fall in blood pressure. Diagnostic changes in her 
serum transaminase activities did not develop until almost a day later (Fig. 12), 
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FIG. 10-Method of decompression of the inferior vena caval and splanchnic 
venous systems during removal of the canine liver and replacement with a homograft. 
A preliminary portacaval shunt has been constructed. This temporary anastomosis, 
connecting the 2 venous systems, allows their decompression with a single extemal 
bypass. (By permission of Surg. Gynec. Obstet. 111:733, 1960.) 
by which time it was thought that the opportunity for reintervention had been 
lost. She died 3 days later after developing hemolysis which was so extreme 
that it was impossible to Bnd a single normal red cell on smears of her periph-
eral blood. 
Two other infant recipients died within one day of operation as a result of 
vascular occlusion. In both, there was a double hepatic arterial supply to 
the recipient liver, the right branch originating from the superior mesenteric 
artery (Fig. 13A), leading to a decision to anastomose the homograft celiac 
axis to the recipient aorta. Both the donor livers had been obtained from chil-
dren who ,vere considerably larger than the recipients and the inferiorly pro-
truding caudate lobes of the homografts compressed the arterial blood supply 
(Fig. 13A). The complication was not appreciated in the first child who died 
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FIG. ll-Angiographic studies performed in a 5-year-old child immediately after 
her death from a head injury. Dye was injected into the common hepatic artery 
(CHA) proximal to the gastroduodenal artery (GDA). 
(Left) Initial injection. Note the smooth course of the right hepatic artery (RHA). 
(Right) The restraining ligaments of the liver have been incised, a cholecystodu-
odenostomy peIformed, and the head of the x-ray table elevated to 60°. The right 
lobe of the liver has rotated down and medially. The course of the left hepatic artery 
(LHA) is undisturbed. However, the right hepatic artery (RHA) is now severely 
kinked where it passes beneath the common duct. (By permission of Ann. Surg. 168: 
392,1968.) 
12 hours later of acute hepatic insufficiency. It was recognized in the second 
patient and the hepatic artery was detached (Fig. 13B) and anastomosed to 
the vessel that originated from the superior mesenteric artery. The portal vein 
thrombosed a day later with death following in a few hours. 
The other 11 patients all survived for at least 35 days and will be considered 
as a group later in the chapter, since valuable postoperative observations were 
made in each case. In these patients it was possible to assess the effectiveness 
of immunosuppressive therapy and to study the process of liver homograft 
rejection for the first time in humans. 
Rejection in Unmodified Recipients 
\Vith renal homotransplantation, the first clinical trials were in patients 
who were not altered by therapy inasmuch as technics of immunosuppres-
sion were not then available. There will never be an occasion with liver homo-
grafts to obtain exactly analogous information. Instead, reliance must be placed 
on extrapolation to man of the events of hepatic rejection in unmodified animal 
recipients. All the studies of this kind have been carried out in dogs and pigs. 
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FIG. 12-Course of a patient whose reconsh-ucted hepatic artery thrombosed a few 
hours postoperatively. The recipient was a 12-month-old, 5.7 Kg. child with extra-
hepatic biliary atresia. The donor was 21 months old and weighed 10.5 Kg. Follow-
ing transplantation, she was returned to the intensive care unit awake and with a 
blood pressure of 150 mm. Hg. Five hours later the blood pressure suddenly fell to 
80 mm. Hg. and she became somnolent. Thrombosis of the hepatic artery was sus-
pected but the serum transaminases remained only slightly elevated for the next 24 
hours; the SCOT and SCPT then rose abruptly. A liver scan performed at this time 
showed almost no isotope uptake by the liver. Hemolysis became so ovelwhelming 
that the hematocrit fell to zero during the last day of life; concomitantly, there was 
rapidly deepening jaundice. At autopsy, the hepatic artery was thrombosed, the 
portal vein was patent and the liver showed massive but incomplete necrosis. (By 
pelmission of Crune & Stratton, 1969.) 
Dogs. If a technically perfect operation is performed, most canine recipients 
of orthotopic homografts recover promptly from anesthesia and are able to 
resume a diet within the next 24 hours. For the ensuing few days, they may be 
scarcely distinguishable for normal animals. 
However, a well ordered and almost invariable sequence of events subse-
quently unfolds. 61 Within 4 or 5 days, manifold evidence of rejection becomes 
evident (Fig. 14). The dogs stop eating. The serum transaminase activities 
increase, usually to high levels, in rough temporal relation to parallel changes 
in that of alkaline phosphatase. Jaundice develops rapidly at the same time. 
The character of the jaundice is of interest; a variable, but substantial, fraction 
of the serum bilirubin is in the direct reacting form (Fig. 15). With the 
development of icterus, conjugated bilirubin appears in the urine, usually 
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FIG. 13-Anomalous hepatic arterial supply encountered in 2 pediatric recipients 
of orthotopic homografts. In each, the larger right hepatic artery originated from the 
superior mesenteric artery, the smaJlleft branch from the celiac axis. 
(A) Attempted aterial reconstruction. The homograft celiac axis was anastomosed 
directly to the recipient aorta. Note the compression of the homograft arterial supply 
by the caudate lobe of the oversized homograft. This was not detected in one case 
and resulted in death 12 hours later. 
(B) In the second patient, it was recognized that the above reconstruction would 
not be satisfactory; the homograft celiac axis was then anastomosed to the anomalous 
vessel originating from the superior mesenteric artery. However, the child died of 
portal vein thrombosis to which the size disparity of the portal vessels probably con-
h·jbuted. (By permission of Crune & Stratton, 1969.) 
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FIG. 14-The biochemical changes usually seen after orthotopic liver transplanta-
tion in the untreated canine recipient. A brief period of good function follows opera-
tion, but deterioration of the biochemical pattern is unrelenting once it has begun. 
(By permission of Year Book Medical Publishers, 1966.) 
before the disappearance of urine urobilinogen. Finally, the stools become 
clay colored. Thus, the syndrome of rejection has features of parenchymal cell 
injury and necrosis, plus an element suggestive of biliary obstruction. 
After the onset of jaundice, survival is uncommon for more than a few days 
despite the fact that complex hepatic functions of protein synthesis and carbo-
hydrate metabolism may be retained surprisingly well 27 .28, 61 until just before 
death. In one of our control series,67 22 of 23 dogs who received livers from 
nonrelated mongrel donors survived for at least 2 days after operation and 
19 (83 per cent) lived for at least 6 days. All the animals were dead by the 
tenth day. The mean survival was 7.1 ± 2.2 SD days. The longest survival 
ever recorded in an untreated mongrel recipient was 31 days. 2s 
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FIG. IS-Character and onset of jaundice in untreated orthotopically transplanted 
dogs. The dots represent total bililllbin determinations for individual animals; the 
solid line connects the mean for each day. The broken line represents the mean of the 
corresponding direct-reacting bilirubin determinations. Note the absence of chemical 
jaundice until the sixth day and its substantial conjugated component. (By permission 
of Surg. Gynec. Obstet.112:135, 1961.) 
The effect of rejection upon hepatic blood flow was studied by Groth.'9 
At the same time that there was biochemical evidence of homograft deteriora-
tion, sharp and progressive reductions were recorded in both hepatic arterial 
and portal venous blood flows (Fig. 16). Groth's companion pathologic studies 
suggested that the immunologically mediated ischemia was due to damage to 
the sinusoidal bed and small veins of the homo grafts. 
Pigs. The foregoing background in dogs was later supplemented by 
analogous studies in untreated pigs, first by Garnier, of Paris,'2,17 and later by 
Peacock and Terblanche et al. ; IG,17 by CaIne,s.o and in our own laboratories. 
In all these investigations, beginning with those of Garnier, the mild and in-
dolent nature of the rejection was noted (Fig. 17). In Peacock's series, for 
example, one of the recipient pigs had survived without any immunosuppres-
sive therapy for more than one year 4 6 and Terblanche 73 has informed us that 
the animal was ultimately sacrificed more than 2 years after operation. Both 
Taffe 22 and Ca]ne 9 and their associates provided evidence that the pig was 
capable of rejecting other kinds of homografts. 
The explanations favored by Jaffe, Symes, and Terblanche 22 for the relative 
blandness of hepatic homograft rejection in pigs included the possibilities that 
the liver was not strongly immunogenic, that its large mass might have played 
a role by means of antigen overload, or that the organ was uniquely capable 
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FIG. 16-Liver blood flow 
as detelmined by the xenon 
isotope (Xe1 33 ) washout tech-
nic. The flows obtained on 
portal venous (FPI) and 
hepatic arterial (FAI) injec-
tion, cardiac output (CO) and 
liver function tests were mea-
sured in 7 unmodified canine 
recipients. The mean values 
± SE are shown, as well as 
the number of observations 
(in parentheses) for each day. 
Note that both the hepatic 
arterial and portal blood 
flows decrease concomitant 
with deterioration of hepatic 
function. (By permission of 
Surgery 63:658, 1968.) 
of Withstanding the resulting host immunologic attack. CaIne has proposed 
another hypotheses-that the liver homograft has an inherent immunosup-
pressive effect. 8 In support of this contention, he cited experience with com-
bined liver and renal homografts. The porcine kidneys, which were rejected 
in the usual way when transplanted alone, now functioned for periods as long 
as several months. 
While CaIne's speculations are intriguing, the specificity of the last finding 
is open to some question, since it has been shown that other combinations of 
organs can lead to a less vigorous host reaction than that evoked by the consti-
tuent parts. The units tested have included multiple gastrointestinal viscera 59 
and the kidney plus spleen. 31 
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FIC. 17-Course of a pig which received an orthotopic hepatic homograft from a 
nonrelated donor. Although no immunosuppressive therapy was ever given, there 
has been neither clinical nor biochemical evidence of rejection at any time post-
transplantation. The animal is still alive with normal liver function more than 8 
months later. Note the sharp decline in the platelet count immediately after surgery; 
thrombocytopenia has also been seen in canine and human recipients of ortJlotopic 
homografts. 
The Effect of Immunosuppression 
There have only been 2 agents, azathioprine and antilymphocyte serum 
(ALS) or its globulin derivative (ALG), which have been definitely proven to 
prolong survival in animals beyond that which can be achieved in nontreated 
controls. Azathioprine was first successfully used in early 1964. A series of 
84 transplantations were performed between nomelated mongrel dogs.67 
Forty-three and 23 recipients from the total of 84 lived for 25 and 50 days, 
respectively. Two of the animals are still in good health more than 4 years 
postoperatively (Fig. 18). 
As the survival statistics imply, azathioprine therapy when used alone pro-
vided good and permanent control of homograft rejection only in the minority 
(about 20 per cent) of experiments. In another third, rejection was not even 
Significantly mitigated. The remaining animals had prolongation of survival 
despite the development of liver function abnormalities; however, they usually 
died, eventually, of hepatic insufficiency (Fig. 19). 
The same kind of spectrum was evident in the canine trials of heterologous 
ALS and ALG. A review of the experimental history of this kind of immuno-
suppressive therapy is beyond the scope of the present discussion. The sub-
stances are prepared by immunizing horses against the species to be eventually 
treated (Fig. 20). When the raw serum or a crude globulin extracted from it 
is injected by any of the common routes, a highly significant effect upon homo-
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FIG. 18-Two recipients of orthotopic hepatic homo grafts from nonrelated canine 
donors. The dog on the right is now 4 years post-transplantation; the one on the left 
is 4% years. Immunosuppressive therapy with azathioprine was stopped 4 months 
after operation in both. Neither animal has shown signs of rejection, subsequently, 
despite discontinuance of treatment. 
graft rejection can be easily demonstrated. This can be achieved whether or 
not doses large enough to cause depression of the lymphocyte count are used. 
In the first trials of ALS and ALG for canine liver transplantation 21 ,6 2, 66 
there were 18 experiments. Ten, 9, 7, and 6 of the recipients survived for at 
least 15, 20, 30, and 50 days; 4 of the animals are still living at 4 months and 
the longest survival was for more than a year (Fig. 21). Similar results were 
later reported by Pichlmayr and Mikaeloff 39, 19 and by Birtch et al. 3 
In the foregOing studies, with both azathioprine and antilymphocyte globulin, 
the consistency with which really long-term survival was obtained was un-
acceptable in terms of potential clinical application. There were at least two 
obvious reasons. First, complete control of rejection was usually not achieved. 
Second, it was difficult to prevent or treat infectious disease complications 
in a standard kennel environment. 'Vhatever the explanation, it is probable 
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FIG. 19-Course of a dog showing incomplete reversal of a rejection episode fol-
lowing orthotopic liver transplantation. Note the severe jaundice which subsequently 
disappeared. Immunosuppression was with azathioprine; the animal also received 
S30-methionine, L-methionine and choline. No alterations in immunosuppression were 
made at the time of rejection. Azathioprine therapy was stopped 127 days after 
operation. Slow deterioration of hepatic function then developed and the dog died 
203 days post-transplantation. The immediate cause of death was perforation and 
bleeding of a peptic ulcer at the esophago-gastric junction. (By permission of Surgery 
58: 131, 1965.) 
that the animal data would have indefinitely discouraged a clinical trial if it 
were not for the example of renal transplantation. 
With the latter procedure, it had been possible to develop, in patients, 
moderately reliable regimens of immunosuppression using combinations of 
agents. Initially, extensive experience was gained with the joint administration 
of azathioprine and prednisone. It was with these 2 drugs that most of the first 
recipients of liver homografts were treated. As mentioned earlier, these patients 
not only obtained poor function from their badly preserved hepatic homografts 
but also had overwhelming postoperative infections. 
Beginning in June 1966, horse ALG was added as an adjuvant agent to 
azathioprine and predisone with the plan of restricting its use to the first 4 
postoperative months. The best information about the benefit of this change 
has come from cases of renal homotransplantation."5,58,nr.,7o With the advent 
of ALG therapy, it was found that mortality, after renal transplantation, was 
reduced in comparison to our past experience, that the homograft function 
was more conSistently maintained" and that these results were possible with 
reduced doses of both azathioprine and prednisone. While there were a num-
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FIG. 20-Schematic representaticn of the preparaticn of antilymphocyte globulin 
(ALG). Horses are injected with lymphoid tissue of the species to be treated; the most 
convenient source of lymphocytes is the cadaver spleen. After repeated immuniza-
tions, the horses are bled and the serum separated. Undesirable anti-red cell, anti-
plasma protein, and anti-thrombocyte antibodies are removed by appropriate absorp-
tions. The desired globulin fraction may be extracted by several methods. At present, 
precipitation with ammonium sulphate is the most practical and reliable technic. 
Antilymphocyte serum has also been raised in other species, including the rabbit, 
goat and cow. (By permission of W. B. Saunders, 1968.) 
ber of toxic side reactions including anaphylaxis with the administration of the 
foreign protein,z3 we have not had an ALG related mortality in more than 100 
cases. 
As a consequence of the encouraging experiences with the kidney, all recent 
recipients of liver homografts have had treatment, not only with azathioprine 
and predisone, but also with horse or rabbit ALG. A typical protocol is shown 
in Fig. 22. 
Acute rejection in modified human recipients. There have been 11 patients 
in our experience in which the value of the triple agent immunosuppressive 
therapy could be assessed. During the early postoperative period, overt 
rejection was prevented in only a single case. In all the others, some degree of 
liver function abnormality, including jaundice, developed within the first few 
weeks (Fig. 23). 
However, the process was a relatively self-limited one and in each instance 
partially or completely reversed without intensification of treatment. The way 
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FIG. 21-The first postoperative year of a dog which was treated with intraperi-
toneal antilymphocyte serum (ALS) for 26 days before and 20 days after orthotopic 
liver transplantation. No other immunosuppression was given. Note the profound 
lymphocytosis late in the postoperative period. The animal finally developed ascites 
and died of chronic liver failure 490 days after operation. (By permission of 
Butterworths, London 1967.) 
in which rejection presented appeared to have a bearing on the ultimate 
prognosis. 
When this developed explosively (Fig. 23) there was suddenly developing 
icterus, associated with very high rises in the serum activities of transaminases 
and alkaline phosphatase. In such cases, the biochemical changes then receded 
almost as abruptly with little or no residual impairment. 
In contrast, the much more indolent rejection seen early in several cases has 
presented a more difficult problem. In these patients, icterus developed in-
sidiously, usually without the severe and disquieting enzyme changes. However, 
reversal did not follow quickly and, in fact, in neither of the 2 recipients in 
whom this syndrome was observed did the bilirubin ever completely return 
to normal. Furthermore, as will be mentioned below, hyperbilirubinemia be-
came even more severe later when the heterologous ALG was stopped. 
Five of the 11 patients are still alive O~I 5, 6, 7, and U~ months after opera-
tion. One of the other patients died of pneumonitis 35 days postoperatively 
at a time when she had normal liver function. The causes of failure in the 
other 5 cases will be returned to below. 
Late re;ection in patients. The above observations have made it clear that 
lethal homograft rejection can be consistently prevented and that less severe 
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FIG. 22-Postoperative course of a 2-year-old child with biliary atresia. Azathio-
prine and prednisone were given on the day of orthotopic transplantation and con-
tinued thereafter in variable doses. Horse antilymphocyte globulin (ALG) was given 
daily for 2 weeks. The dosage schedule was then attenuated and finally terminated 
after 16 weeks. Nine weeks later jaundice reappeared accompanied by increases in 
the serum transaminases and alkaline phosphatase, and depression of the serum pro-
tein. Increasing the prednisone doses failed to control the rejection. Institution of a 
course of rabbit ALG resulted in a partial reversal of the enyzme and protein abnor-
malities; the serum bilirubin has remained elevated, however. (By permission of 
Grune & Stratton, 1969.) 
forms are, at least partially, reversible in the early postoperative period. The 
picture has been less encouraging in terms of the chronic function of the 
transplants. As described earlier, the treatment protocol involved immediate 
triple drug therapy but with discontinuance of ALG after an arbitrary period, 
which was selected as 4 months; in some of the cases the duration of globulin 
administration was made shorter than this because of serologic or clinical 
evidence of sensitization to the horse protein. 
In 6 of the 11 patients who lived for 35 days or more, ALG was stopped. 
In 5 of the cases, jaundice recurred within 1-8 weeks, necessitating drastic 
revisions in therapy. An example is shown in Figure 22. The recipient, a 
2-year-old child with biliary atresia, had no overt rejection for the first 6 post-
operative months, but then became jaundiced within a few weeks of cessation 
of globulin therapy. The late rejection was treated with increased prednisone 
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FIG. 23-The course of a 42-year-old man whose indication for orthotopic trans-
plantation was hepatoma. Rejection was diagnosed after one week but rapidly and 
completely resolved without intensification of therapy. ALG therapy has never been 
discontinued. Late rejection has not been seen in this patient nor in another patient 
who also is still receiving ALG. 
doses and rabbit ALe which was used because a potentially sensitizing course 
of horse ALG had already been given. The abnormalities in serum enzymes, 
which had accompanied the delayed rejection crises, were promptly restored 
toward normal but the icterus has remained the same for many weeks. 
It has now become evident that many, if not most, recipients of liver 
homo grafts are dependent on ALe treatment for continuing good function of 
their transplants. We have had only 2 reCipients among the 11 under discus-
sion who have not had one or more bouts of late rejection. In both, treatment 
with horse ALe has never been discontinued (Fig. 23). There seems to be no 
reason in future cases to restrict the interval of globulin therapy to any rigid 
segment of time. Rather, it will probably be advisable to continue injections 
until they can no longer be tolerated. 
Unfortunately, the time it takes to become dangerously sensitized to the 
foreign protein is highly variable and in some cases it may be rather short. 
Among the reCipients of kidney homografts, more than a third have had to 
have ALe discontinued before the end of 4 months. In an occasional patient, 
treatment had to be stopped within less than 4 weeks, either because of intense 
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local reactions of the injectate or because of the occurrence of anaphylactic 
reactions. Consequently, other alternative schedules of ALG administration 
are badly needed. In a recent publication the first experience was cited with a 
"blitzkrieg" approach GG in which an attempt was made to induce an early and 
prolonged tolerance of the kind that has been described in rodents. 36 ,40 
An alternative solution might be to switch to another species as a source 
for the heterologous serum in the event of sensitization. In our laboratories, 
ALS is currently being raised in 4 different species in order to provide a wider 
choice. Although horse globulin has been used routinely, rabbit ALG has 
been given to 2 of our liver recipients as a second line measure (Fig. 22 and 25). 
It is still too early to speculate on the ultimate seriousness of late rejection. 
Surprisingly, there has been, usually, little immediate clinical deterioration. 
One reason probably is that most hepatic functions have not been seriously 
deranged. The usual syndrome is quite indistinguishable from that of chronic 
extrahepatic biliary obstruction: an elevated serum bilirubin containing a large 
direct reacting fraction with a parallel increase in alkaline phosphatase activity. 
The serum transaminase activities, liver based clotting factors, and serum pro-
teins have remained nearly normal (Fig. 22). In one patient, the findings were so 
suggestive of duct obstruction that re-exploration was carried out 3.12 months 
after transplantation. Operative cholangiography revealed a patent anastomosis 
and a well-preserved intrahepatic duct system (Fig. 24). The most prominent 
feature of the biopsy of the homograft at that time was intrahepatic cholestasis. 
A moderate infiltration of small lymphocytes was noted around the small bile 
ducts; this pOSSibly represented a degree of chronic cholangitis. No appreCiable 
vascular lesions were seen and there was no centrolobular cellular infiltration. 
Thus, there was little histologic evidence of rejection. 
So far, none of the 11 patients who have lived for at least one postoperative 
month has died as a consequence of late homograft rejection. Four of the 
5 delayed deaths were due to occlusion of the right hepatic artery, to be men-
tioned later. The fifth patient died of pneumonitis after 35 days and the sixth 
patient succumbed to carcinomatosis 400 days after transplantation. 
Retransplantation 
The orthotopic transplantation of either of the unpaired vital organs, the 
liver and the heart, presents a special kind of problem. In both instances, im-
mediate life-sustaining function of the transplant must be obtained, which 
cannot, thereafter, be permitted to completely cease, even for brief periods. 
The clinical setting is, thus, different from that encountered with the kidney. 
Complete failure of a renal homograft does not cause sudden death. Moreover, 
the availability of dialysis technics permits removal of a rejected organ and 
maintenance of the patient in relatively good health for as long as necessary 
before a new kidney can be found . This ordered chain of events cannot be 
followed with either the liver or the heart for obvious reasons. Nevertheless, 
one patient in our institutions has recovered satisfactorily from 2 consecutive 
orthotopic liver transplantations. 
The recipient was 23 months old at the time of his first operation for biliary 
atresia. He received the liver of a 31f-year-old donor with whom he had an 
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FIG. 24-0perative cholangiogram 3h months post-transplantation. The duodenum 
was opened and a catheter inserted through the cholecystoduodenostomy into the 
gallbladder. X-rays taken after injection of contrast mcdium revealed a patent 
anastomosis and a well preserved intrahepatic duct system. The patient is now an 
outpatient, 7 months post-transplantation. Her bilirubin is 7 mg. per cent. The 
original diagnosis was hepatoma, from which she has no demonstrable metastases. 
GB = gallbladder; CD = cystic duct; CHD = common hepatic duct; CBD = common 
bile duct (ligated). 
almost perfect histocompatibility match. Unfortunately, it became necessary 
to stop horse ALG 17 days later because of intense local rcactions at the injec-
tion sites. Rejection appeared almost immediately and could not be reversed 
(Fig. 25). The child became febrile, had a persistent tachycardia, developed 
anasarca and appeared to be moribund. 
Nine weeks after the first transplantation, the rejecting homograft was 
removed and replaced with the liver of a 7-year-old donor; the histocompati-
bility match was much less favorable than originally. Life-sustaining function 
has now been maintained for more than O~ months. However, the slowly 
developing and incompletely reversible kind of indolent rejection mentioned 
earlier has occurred (Fig. 25); the child remains in good condition, nevertheless. 
Rabbit ALG was used during the second post-transplantation period. 
The technical difficulties of removing the enormously enlarged (880 Gr.) 
homograft were not as great as had been feared. Upon opening the abdomen, 
the liver surface was mottled and generally discolored (Fig. 26). A plane was 
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FIG. 25-An example of orthotopic retransplantation of the liver. Uncontrolled 
rejection of the first homograft occurred shortly after horse ALG had been stopped 
because of severe reactions at the injection sites. Desensitization to horse protein was 
attempted. The patient became febrile and developed anasarca. Following retrans-
plantation 9 weeks after the first operation, the enzyme abnormalities promptly re-
versed and the icterus cleared, only to reappear a month later despite treatment with 
rabbit ALG. 
developed inside the thin fibrous tissue which formed a pseudocapsule around 
the organ. The recipient vessels were identified and their full previous lengths 
retained. 
The blood supply to the extirpated organ was completely intact, although 
several small thrombi could be identified grossly in the peripheral radicles 
of the intrahepatic portal tracts. Histologically, there was dense infiltration of 
the homograft with mononuclear cells of which many were pyroninophilic. 
However, the most striking abnormality was thickening of the intima of small 
branches of hepatic artery leading to narrowing or obstruction of these small 
vessels (Fig. 27). The thickened intima consisted of many large cells with 
abundant cytoplasm containing fine droplets of fat. Increased fibrosis, intra-
hepatic cholestasis, and centrolobular necrosis were also present. 
Regional Hepatic Gangrene 
In describing the technic of orthotopiC liver transplantation, it was 
mentioned that right hepatic arterial thrombosis was proved in 4 of the first 
4 infant patients who achieved extended survival; the same complication 
probably occurred in a fifth recipient who survived for more than a year. The 
etiology of the lobar arterial thrombosis appears to be a complex one, which 
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FIG. 26--A rejecting human homograft 9 ,veeks after orthotopic transplantation. 
The abdomen has just been opened in preparation for removal of the liver and re-
transplantation. All vascular anastomoses and the cholecystocluodenostomy were 
found to be patent. The surface of the enormously enlarged organ was mottled and 
discolored. After sectioning, many superficially located infarcts were seen. The 
homograft weighed 880 Gm. 
has at least a partially mechanical genesis 07 added to an important element 
of uncontrolled rejection. . 
Whatever its cause, the events which follow constitute a special syndrome 
not seen after transplantation of other organs. The uniqueness of the complica-
tion is undoubtedly explained by the interposition of the liver between the 
intestine and the heart and by the fact that it is also connccted to the intestine 
through the biliary tract anastomosis. The result has been massive bacterial 
invasion of the dearterialized liver tissue by intestinal microorganisms. 
The course of one of these patients is shown in Fig. 28. After a benign 
early convalescence, the child suddenly became acutely febrile and developed 
gram negative septicemia. A liver scan showed a large Rlling defect in the right 
liver lobe. Debridement of the necrotic tissue was carried out in all 5 cases. 
In 2, death followed within a few hours or days; 2 other children survived 
only to die 4 and 6 months later, respectively, with chronic liver failme and 
widespread upper abdominal sepsis. 
The fifth victim of this kind of vascular catastrophe survived for more than 
a year and finally died of metastases of the original hepatoma. A postmortem 
angiogram showed that the left hepatic branch also had become occluded, 
probably at a later time (Fig. 29). The only demonstrable arterial supply to 
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FIG. 27-Biopsy taken just before removal of the homograft shown in Fig. 26. A 
portal tract is shown. There are large numbers of infiltrating mononuclear cells. A 
branch of the hepatic artery can be seen to be greatly narrowed by large intimal cells 
with foamy cytoplasm. The internal elastic lamina of the vessel is marked with an 
arrow. Elastic stain ( x 300). (The photomicrograph was supplied by Dr. K. A. 
Porter of London, England.) 
the homograft was a twig from the right phrenic artery. It is of interest that 
a patient of Birtch and Moore also lived for many weeks after complete hepatic 
dearterialization, apparently with little disturbance of liver function. 2 
Recurrence of Liver Malignancy 
In 5 of the 7 attempts at orthotopic transplantation made at our institution 
before the summer of 1967, the indication for operation was primary hepatic 
malignancy. The early death of these patients made observations impossible 
about the effect of the procedure upon the natural history of this disease. The 
more recent experience is still too limited to permit a decisive conclusion 
about the question. However, the appearance of metastases in 2 of the 4 more 
recently treated patients is a discouraging notation. One of the recipients 
died of infection 35 days post-transplantation and did not have detectable 
residual tumor at autopsy. Another is alive without recurrent disease after 
7 months. A third developed evidence of pulmonary metastases within a few 
months (Fig. 30) and the fourth died of widespread metastatic carcinomatosis 
(Fig. 31) 400 days after operation. 
Thus, total hepatectomy certainly extends local resectability but does not 
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FIG. O~qhe first 9 post-transplantation months of an 18-month-old child with 
hepatoma who survived 400 days after orthotopic transplantation. Note the high rises 
in the serum transaminases which occurred at the time of the initial liver infarction. 
The later septicemia developed when the patient became leukopenic during treatment 
with vincristine for tumor metastases. The thoracotomy was for removal of an unex-
panded right upper lung lobe. The first 2 laparotomies were for excision of tumor 
recurrences. Liver function remained stable until several weeks before death. At 
autopsy the cholecystoduodenostomy was found to be compressed by tumor and the 
entire hepatic artery was occluded. (By permission Ann. Surg. 168:392, 1968.) 
ensure against tumor spread. Indeed, there is reason to be fearful that the 
immunosuppressive therapy necessary to prevent rejection of the homograft 
may itself be a factor which could accelerate the dissemination of residual 
neoplasm. According to Burnet's hypothesis,7 the consequent immunologic 
crippling should result in at least a partial loss of the normal surveillance 
mechanism by which mutant cells are identified as "non-self" and eliminated 
or, presumably, otherwise restricted in their growth potential. That this view 
may have some validity is attested by the ease with which carcinoma has been 
accidentally transplanted from renal donors dying of malignancy but whose 
kidneys were not grossly involved 18,35,80 and by Penn's report 47 of an increased 
incidence of malignant neoplasia ariSing de novo in recipients of renal homo-
grafts that had been obtained from normal donors. An observation even more 
relevant to the problem under discussion was recently made by Williams et aI. 79 
who performed rena] homotransplantation in a child 6 months after excision 
of a Wilm's tumor. Sixteen months after transplantation, at a time when cure 
of this kind of neoplasm would usually have been assured under normal con-
ditions, metastases became apparent, leading to death within a few weeks. 
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FIG. 29-Postmortem angiogram of a patient who lived 400 days after orthotopic 
transplantation for hepatoma. The common and proper hepatic arteries are occluded. 
A small branch (arrow) of the right phrenic artery (RPA) is the only demonstrable 
arterial supply to the homograft. Thrombosis of the right hepatic artery occurred 
about Pg~ weeks after transplantation; the left probably closed some time later. The 
superior mesenteric artery (SMA) and the left gastric artery (LGA) are displaced by 
metastatic tumor. C. axis = celiac axis; LGA = left gastric artery; LPA=left phrenic 
artery; RPA = right phrenic artery; RRA=right renal artery; SA=splenic artery; 
SMA=superior mesenteric artery. 
AUXILIARY TRANSPLANTATION 
It is highly probable that far more auxiliary than orthotopic transplantations 
have been attempted. All these efforts to provide a second liver have led to 
early death of the recipients; unfortunately, only a few such cases have been 
reported." 20,3R. 3 0, 6 4,6 5 
The special appeal of this kind of compromise operation is that the residual 
function of the patient's own diseased liver is retained. Whether or not this is 
sufficient reason to select a method of therapy which has yielded inferior 
results in experimental animals is open to serious question. The longest sur-
vival ever reported in which the life-sustaining potential of an auxiliary canine 
graft was proved has only been 126 days.34 
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Special Metabolic Considerations 
As was mentioned earlier, the first experiments in whole organ liver homo-
grafts were carried out in dogs by Welch,'B placing the extra organ in the 
right paravertebral gutter and revascularizing it from the lower abdominal 
vessels (Fig. 32). The organs elaborated bile for a few days and wcre then 
rejected, as would be expected in unmodified recipients. 
'''' hen the same technics were used tcn years later in immunosuppressed 
recipients a curious and disquieting observation was made. Auxiliary livers, 
inserted by a modification of 'Welch's technic, undenvent rapid shrinkage 
which was usually evident within 2 weeks and which was very advanced 
after one month (Fig. 33). The loss in size was due primarily to dissolution 
of hepatocytes. 
The explanation for this finding was worked out in principle by 
Marchioro 33,34 and elaborated upon by a number of subsequcnt authors. 
Taken together, thcse studies have shown that there is a compctition between 
coexisting livers which can be unbalanced in favor of one organ or the other 
in a variety of ways. For example, a distinct advantage is given to a liver if it 
receives a portal inHow from the splanchnic venous bed, especially if thc other 
liver is deprived of this nutritional sourcc. As would be expected, the compet-
itive capability of the liver can be inhibited in other 'Nays including ligation 
of the biliary drainage system or by reducing the total blood flow, as with an 
Eck fistula. 
In cHnical transplantation, it would be anticipated that the competition 
between the two organs would be heavily biased in favor of the homograft 
according to the extent of the disease present in the host liver. The competitive 
potential of the patient's organ would be expected to be very poor with end-
stage cirrhosis, but might not be by any means so retarded with congenital 
biliary atresia, in which satisfactory parenchymal function is often retained 
for a surprisingly long time. 
The quantitative privilege which must bc extended to the homograft is 
probably variable from case to case, depending upon the magnitude of rejec-
tion which is encountered. This was particularly well demonstrated in the 
experiments of Halgrimson 20 and Daloze 14 who showed that if the host and 
homograft livers were given equivalent physiologic advantages, the recipient 
liver flourished, whereas the organ under immunologic attack promptly under-
went atrophy. Thus, it would be predicted that both a elose donor-recipient 
histocompatibility match and highly efficient immunosuppression would carry 
especially important therapeutic implications in the application of auxiliary 
transplanta tion. 
Clinical Auxiliary Transplantation 
Our own experience is confined to 4 patients, 3 with Laennec's cirrhosis and 
the other "vith biliary atresia. In the case of biliary atresia, the recipient and 
donor were 16 and 7 months old, respectively. The homograft was placed 
in the left upper quadrant after performing splenectomy and revaseularized 
as shown in Figure 34. There was not enough room in the abdomen for the 

FIG. 30-Chest x-rays of a 42-year-old recipient whose 
indication for hepatic transplantation was hepatoma. 
(A) One and a half weeks after transplantation. There 
was no evidence of pulmonary metastases. 
(B) A suspicious lesion (arrow) was first detectable radio-
graphically 80 days after operation. 
(C) Two months after recurrent tumor was first sus-
pected, other metas tases became evident in both lungs. He 
is asymptomatic 6 months after transplantation. 
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FIG. 31-Pulmonary metastases in an 18-month-old recipient one year after ortho-
topic liver transplantation for hepatoma. Evidence of spread was first noted 3 
months after transplantation. The patient died 400 days postoperatively. 
auxiliary organ. When the incision was reapproximated, the arterial supply 
was kinked off, leading to thrombosis. The organ was removed and the recipi-
ent died a few hours later. 
Functioning homografts were obtained in the other 3 patients who were 50, 
47 and 48 years old. The homografts in the first 2 recipients were taken from 
79 and 12-year-old donors and revascularized in the right paravertebral gutter 
by modifications of the technic shown in Fig. 35. The recipients who had 
been jaundiced and in semicoma prior to operation were, temporarily, con-
siderably improved (Fig. 36). However, rejection followed within a few days. 
Ultimately both patients developed leukopenia and died from widespread 
sepsis. It is unfortunate that heterologous ALG was not available at the time 
these patients were treated, since good initial homograft function was obtained 
in both, but could not be sustained for more than a few days, even with doses 
of immunosuppressive drugs which proved to be highly toxic. 
More recently, a 48-year-old patient with cirrhosis was given the liver of a 
newborn 3.1 Kg. anencephalic. The tiny homograft was used to replace the 
spleen. The patient had hepatorenal syndrome before operation and required 
emergency dialysis before being taken to the operating room. His course after 
transplantation is summarized in Fig. 37. There was little or no evidence of 
new hepatic function, possibly because of the small size and immaturity of the 
organ. The recipient died 25 days later of hepatic and renal insufficiency and 
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FIG. 32-Auxiliary liver homotransplantation in dogs, using a modification of 
Welch's method. The reconstituted portal blood supply is from the inferior vena cava; 
the hepatic artery is anastomosed to the iliac artelY. Cholecystoduodenostomy is 
performed. (By permission of Ann. Surg. 160:411, 1964.) 
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FIG. 33-The auxiliary homograft (right) and the canine recipient's own liver 
45 days after auxiliary transplantation. The auxiliary liver was placed in the right 
paravertebral gutter using a modification of Welch's method, as shown in Fig. 32. 
Thus, only systemic venous blood passed to the transplant portal vein. Note the well 
preserved but dimensionally reduced general structure of the homograft. The gall-
bladder did not shrink proportionately. (By permission of Ann. Surg. 160:411 , 1964.) 
of pneumonitis. At autopsy all the reconstructed vascular channels entering 
and leaving the liver were patent. 
It is of interest that, in the 3 adult cases, there was no evidence of atrophy in 
any of the 3 homografts that were in residence for 22, 25 and 34 days. Although 
the organs had some histologic evidence of congestion, there were few signs 
of active immunologic rejection. Similar flndings were present in the patient 
of Absolon who lived ahnost 2 weeks. In the other reported cases of auxiliary 
liver transplantation, death occurred too soon to permit valuable histolOgic 
observations about rejection.1.3S.50 
PRESENT STATUS 
Although all the flrst attempts at orthotopic liver transplantation in humans 
resulted in early recipient death, the experience compiled since the summer of 
1967 has established that this procedme can prolong life in patients dying of 
hepatic disease. To date, the longest smvival has been a few days more than 
13 months. Nevertheless, the operation has proved to b6 a hazardous one, not 
only because of technical difficulties in its performance, but also because of a 
number of complications that have been seen at a later time. The latter 
included regional hepatic gangrene due to thrombosis of a lobar arterial supply 
and late rejection after discontinuance of heterologous ALG therapy. 
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FIG. 34-Technic used for auxiliary transplantation in a 16-month-old female with 
biliary atresia. The donor was a 7-month-old child. The homograft portal vein and 
hepatic artery are anastomosed to the spleniC vein and common iliac artery, re-
spectively. Note the angulation near the origin of the left common iliac artery. Kink-
ing of this segment at the time of closure of the abdomen resulted in thrombosis, 
which necessitated removal of the homograft. (By permission of Arch. Surg. (Chicago) 
93:107,1966.) 
Results with auxiliary liver transplantation in animals have been inferior to 
those with the orthotopic operation, at least partly because the homograft must 
not only face immunologic rejection, but must also, apparently, compete for 
metabolic substrate with the host's own liver. Although the competition be-
tween the two livers would not be expected to be such a severe problem in 
patients dying with hepatic failure, survival in hmnan recipients of auxiliary 
homo grafts has not yet exceeded 34 days. 
§l'A6lf II 
STAGE 1. 
FIG. 35--Technic of auxiliary liver transplantation. Similar operations were used for 2 adults with alcoholic cirrhosis. 
Stage I (left)-A portacaval shunt was perfomled transabdominally for emergency control of variceal hemorrhage. 
Stage II (right)-One of several days later, transplantation was carried out utilizing part of the Stage I incision (inset). 
(A) Operative field before implantation of the homograft. 
(B) Completed transplanation. The celiac axis of the homograft is anastomosed to the hypogastric artery (as shown) or to the side of the 
terminal aorta. The portal venous inflow is from the external iliac vein ; the homograft suprahepatic inferior vena cava is anastomosed to 
the transected recipient inferior vena cava. Alternately, the portal vein may be revascularized from the distal end of the transected vena 
cava. Roux-en-Y internal biliary drainage to the jejunum is used. (By pelmission of Arch. Surg. (Chicago) 93: 107, 1966.) 
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FIG. 36-Clinical course of a 47-year-old recipient who received an auxiliary 
hepatic homograft from a 12-year-old donor. The early rise in SCOT is probably 
ascribable to ischemic injury to the homograft. Improvement in liver function, as 
evidenced by the recovelY in prothrombin time and the reduction in serum bilirubin, 
followed in the immediate postoperative period. However, a rejection crisis was 
diagnosed at 4 days after which jaundice deepened, although never to the preopera-
tive level. Leukopenia developed during the third postoperative week. The white 
count remained depressed despite discontinuance of azathioprine and the patient died 
of sepsis on the thirty-fifth day. Exploration on the thirty-first day was for gastro-
intestinal bleeding, which, at autopsy, was proved to be due to invasive moniliasis of 
the small bowel; vagotomy and pyloroplasty were performed. (By permission of 
Arch. Surg. (Chicago) 93: 107, 1966.) 
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FIG. 37-The course of a patient with Laennec's cirrhosis and hepatorenal syn-
drome who received a newborn aUxiliary homograft. The transient reduction of 
jaundice was probably due to the blood transfusions during operation. The patient 
required emergency hemodialysis before operation and at frequent intervals there-
after. Death on the twenty-fifth day was due to hepatic and renal failure and to 
pneumonitis. 
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